Clinical Trial Update: Japan Alteplase Clinical Trial (J-ACT): Efficacy and Safety Study of Tissue Plasminogen Activator (Alteplase) for Ischemic Stroke [Phase 3]

View source ↗

Summary

Phase 3 Japanese trial (J-ACT) evaluating alteplase for ischemic stroke completed with results posted in 2012, reporting efficacy and safety data.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Alteplase (Activase) (alteplase)

Snippet

Sponsor: Tanabe Pharma Corporation | Conditions: Cerebral Infarction, Brain Ischemia | Phase 3 | Status: COMPLETED | Results posted: 2012-02-24